Physician profile
Seth Dukes
NPI 1316258221
$7,369.28
in general payments reported to CMS, 2019-2025
11 companies · $1,357 in 2025
The $1,357 reported for 2025 was more than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $125 · 2020: $272 · 2022: $815 · 2023: $2,371 · 2024: $2,429 · 2025: $1,357.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,867 · Food and Beverage: $1,291.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,866.86 |
| Food and Beverage | $1,290.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Olympus Corporation of The Americas | $4,431.42 | 2023-2025 | Single Use Electrosurgical Knife Kd-655, Disposable Distal Attachment, Single Use Electrosurgical Hemostatic Forceps |
| Boston Scientific Corporation | $1,806.63 | 2022-2025 | Overstitch Endoscopic Suturing System, Axios, Apollo Esg Nxt System |
| Abbvie INC. | $361.17 | 2020-2023 | |
| Medtronic, INC. | $159.44 | 2023 | Endoflip, Gi Genius |
| Laborie Medical Technologies Corp. | $127.82 | 2023 | |
| Regeneron Healthcare Solutions, INC. | $124.99 | 2023 | Dupixent |
| Intercept Pharmaceuticals, INC. | $124.77 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $119.27 | 2022 | |
| Mallinckrodt Hospital Products INC. | $68.86 | 2023 | Terlivaz |
| Cook Medical LLC | $28.62 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.29 | 2024 | Trulance |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Seth Dukes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.